These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 8936323)

  • 41. Nuclease-sensitive binding of an Actinobacillus actinomycetemcomitans leukotoxin to the bacterial cell surface.
    Ohta H; Kato K; Kokeguchi S; Hara H; Fukui K; Murayama Y
    Infect Immun; 1991 Dec; 59(12):4599-605. PubMed ID: 1937819
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Leukotoxin confers beta-hemolytic activity to Actinobacillus actinomycetemcomitans.
    Balashova NV; Crosby JA; Al Ghofaily L; Kachlany SC
    Infect Immun; 2006 Apr; 74(4):2015-21. PubMed ID: 16552030
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Identification and expression of the Actinobacillus actinomycetemcomitans leukotoxin gene.
    Lally ET; Kieba IR; Demuth DR; Rosenbloom J; Golub EE; Taichman NS; Gibson CW
    Biochem Biophys Res Commun; 1989 Feb; 159(1):256-62. PubMed ID: 2647082
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Epigallocatechin gallate alters leukotoxin secretion and Aggregatibacter actinomycetemcomitans virulence.
    Chang EH; Brown AC
    J Pharm Pharmacol; 2021 Mar; 73(4):505-514. PubMed ID: 33793838
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Rapid and specific detection of the leukotoxin sequences of Actinobacillus actinomycetemcomitans from periodontal pockets by the polymerase chain reaction.
    Lin CY; Wong MY; Jeng JH; Chang WK; Kuo MY
    J Formos Med Assoc; 1994 Apr; 93(4):289-93. PubMed ID: 7914769
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Lipopolysaccharides mediate leukotoxin secretion in Aggregatibacter actinomycetemcomitans.
    Tang G; Kawai T; Komatsuzawa H; Mintz KP
    Mol Oral Microbiol; 2012 Apr; 27(2):70-82. PubMed ID: 22394466
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Inhibition of Actinobacillus actinomycetemcomitans leukotoxicity by bacteria from the subgingival flora.
    Johansson A; Hänström L; Kalfas S
    Oral Microbiol Immunol; 2000 Aug; 15(4):218-25. PubMed ID: 11154406
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Directed genomic integration in Actinobacillus actinomycetemcomitans: generation of defined leukotoxin-negative mutants.
    Kolodrubetz D; Phillips LH; Ezzo PJ; Kraig E
    Infect Immun; 1995 Jul; 63(7):2780-4. PubMed ID: 7790100
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The production and evaluation of Pasteurella haemolytica leukotoxin in the supernatant of submerged cultures in fermenters.
    Odendaal MW; Ellis CE
    Onderstepoort J Vet Res; 1999 Dec; 66(4):265-72. PubMed ID: 10689699
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Clonal diversity of Actinobacillus actinomycetemcomitans isolates from young adults with minimal periodontal disease.
    Macheleidt A; Müller HP; Eger T; Putzker M; Zöller L
    J Periodontal Res; 1999 May; 34(4):179-87. PubMed ID: 10444741
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The cell cycle-specific growth-inhibitory factor produced by Actinobacillus actinomycetemcomitans is a cytolethal distending toxin.
    Sugai M; Kawamoto T; Pérès SY; Ueno Y; Komatsuzawa H; Fujiwara T; Kurihara H; Suginaka H; Oswald E
    Infect Immun; 1998 Oct; 66(10):5008-19. PubMed ID: 9746611
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Membrane association and destabilization by Aggregatibacter actinomycetemcomitans leukotoxin requires changes in secondary structures.
    Walters MJ; Brown AC; Edrington TC; Baranwal S; Du Y; Lally ET; Boesze-Battaglia K
    Mol Oral Microbiol; 2013 Oct; 28(5):342-53. PubMed ID: 23678967
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Anaerobic neutrophil-dependent killing of Actinobacillus actinomycetemcomitans in relation to the bacterial leukotoxicity.
    Johansson A; Sandström G; Claesson R; Hänström L; Kalfas S
    Eur J Oral Sci; 2000 Apr; 108(2):136-46. PubMed ID: 10768727
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Protease inhibitors, the responsible components for the serum-dependent enhancement of Actinobacillus actinomycetemcomitans leukotoxicity.
    Johansson A; Claesson R; Belibasakis G; Makoveichuk E; Hänström L; Olivecrona G; Sandström G; Kalfas S
    Eur J Oral Sci; 2001 Oct; 109(5):335-41. PubMed ID: 11695755
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Profound Effects of Aggregatibacter actinomycetemcomitans Leukotoxin Mutation on Adherence Properties Are Clarified in in vitro Experiments.
    Velusamy SK; Sampathkumar V; Godboley D; Fine DH
    PLoS One; 2016; 11(3):e0151361. PubMed ID: 26977924
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Inducible bacteriophages of Actinobacillus actinomycetemcomitans.
    Loftus A; Delisle AL
    Curr Microbiol; 1995 May; 30(5):317-21. PubMed ID: 7766161
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Mutational analysis of the putative leukotoxin transport genes in Actinobacillus actinomycetemcomitans.
    Guthmiller JM; Kolodrubetz D; Kraig E
    Microb Pathog; 1995 May; 18(5):307-21. PubMed ID: 7476096
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Molecular pathogenicity of the oral opportunistic pathogen Actinobacillus actinomycetemcomitans.
    Henderson B; Nair SP; Ward JM; Wilson M
    Annu Rev Microbiol; 2003; 57():29-55. PubMed ID: 14527274
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cytolethal distending toxin of Actinobacillus actinomycetemcomitans. Occurrence and association with periodontal disease.
    Tan KS; Song KP; Ong G
    J Periodontal Res; 2002 Aug; 37(4):268-72. PubMed ID: 12200970
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Conformational studies of Actinobacillus actinomycetemcomitans leukotoxin: partial denaturation enhances toxicity.
    Lear JD; Karakelian D; Furblur U; Lally ET; Tanaka JC
    Biochim Biophys Acta; 2000 Feb; 1476(2):350-62. PubMed ID: 10669799
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.